Recent studies have indicated that there are many barriers to successful systemic gene delivery via cationic lipid vectors using the intravenous route. The purpose of this study was to investigate the effect of binding and interaction between erythrocytes, a major constituent of blood cells, and the complexes, in relation to the role of the helper lipid, on the in vivo gene delivery to the lung following intravenous injection. We used three types of cationic lipid vectors, DNA-DOTMA/Chol liposome complexes, DNA-DOTMA liposome complexes, and DNA-DOTMA/DOPE liposome complexes. Although the three types of vectors bind to murine blood cells in vivo and in vitro, DOTMA/Chol and DOTMA complexes with a higher in vivo transfection activity do not induce fusion between erythrocytes, whereas DOTMA/DOPE complexes, a less efficient vector in vivo,
Introduction
Cationic liposomes have been used as a nonviral gene delivery system for both in vivo and in vitro transfection. [1] [2] [3] In particular, some features of cationic liposomemediated gene transfer, such as simplicity of preparation, no limit on the size of the DNA to be delivered, and low immunogenicity, make it attractive as an efficient strategy for in vivo gene therapy. To develop a successful gene delivery system in vivo, many studies have been carried out in laboratories around the world to obtain a better understanding of the structure of DNA-cationic liposome complexes and their mechanism of delivery. [4] [5] [6] [7] Recently, there have been some studies showing that in vivo gene transfer using cationic liposomes is successful in animals and that significant therapeutic effects can be produced.
induce fusion between the erythrocytes after a short incubation period. Pre-incubation of DOTMA/DOPE complexes with erythrocytes significantly reduced the transfection efficiency while DOTMA/Chol-and DOTMA complexes were more resistant to such treatment. The differences in the physicochemical and structural properties of these complexes could explain the differences in interaction with erythrocytes and subsequent gene expression. Lipids in DOTMA/Chol and DOTMA complexes have a stable lamellar structure. However, lipids in DOTMA/DOPE complexes have a highly curved structure with high fluidity. These results indicate that the interaction with erythrocytes depends on the properties of the cationic lipid vectors and this is an important factor for intravenous gene delivery using cationic lipid vectors. Gene Therapy (2001) 8, 677-686.
Most of the cationic liposomes used for transfection consist of cationic lipids and neutral helper lipids. Helper lipids are considered to affect various properties of DNA-cationic liposome complexes and play a very important role in efficient gene transfer. For in vivo gene transfer, the choice of helper lipids depends on the administration route. Intratracheal or intratissue gene delivery using plasmid DNA/DOPE-containing liposome complexes has been shown to be very efficient.
1,2,13,14 DOPE has been considered to be critical for cationic liposome-mediated transfection because it has a strong destabilizing effect on lipid bilayers due to its small head group and bulky acyl chains. 1, 13 Most commercially available cationic liposomes contain DOPE as a helper lipid. DOPE has a high propensity to form a hexagonal phase and DNA/DOPE-containing liposome complexes in which lipids have a hexagonal form fused rapidly with anionic liposomes. 15 DOPE-facilitated fusion between the cationic lipid vectors and the endosomal membrane of transfected cells results in cytosolic release of DNA and subsequent enhanced gene expression. [16] [17] [18] Replacement of DOPE with another neutral phospholipid of the same acyl chain composition, dioleoylphosphatid-ylcholine (DOPC), abolishes most of the transfection activity of cationic lipid vectors. 1, 13 DNA/DOPC-containing liposome complexes, in which lipids have a lamellar form, bound stably to anionic liposomes and no fusion was observed. 15 The structural properties, which are affected by helper lipids, are critical for gene expression.
In contrast, when DOPE was used as a helper lipid, the transfection activity after intravenous injection was significantly impaired and cationic liposomes in which DOPE is replaced with cholesterol (Chol) exhibit much greater in vivo transfection activity after intravenous injection, particularly in the lung. [19] [20] [21] [22] This might be due to a difference in the biological environment where an interaction between the lipid vectors and target cells takes place. Cationic lipid vectors are able to interact with various types of biological components, eg serum proteins and pulmonary surfactants, probably due to their strong positive charge. In the case of intravenous administration, cationic lipid vectors interact with blood components by electrostatic interaction. 23 It has been suggested that the association of serum proteins might be a major factor limiting intravenous gene delivery and that a difference in the stability between DOPE-containing vectors and Chol-containing vectors in serum could explain the difference in intravenous transfection efficiency.
21,22 DOPE-containing vectors are able to recruit larger amounts of serum proteins than Chol-containing vectors and interactions of lipid vectors with serum proteins leads to the disintegration of lipid vectors, DNA release and degradation.
On the other hand, there is no published report describing how plasmid DNA-cationic liposome complexes with different liposomal formulations interact with blood cells, another major component of the blood. Blood cells account for approximately half the blood volume. Blood cells, including erythrocytes, leukocytes and platelets, have negative charges on their surface and an electrostatic interaction may occur between these cells and cationic lipid vectors immediately after intravenous administration. Moreover, there is no information about the relationship between the interaction with blood cells and the structural and physicochemical properties of the complexes. McLean et al 24 reported that the number of leukocytes and platelets fell after intravenous injection of DNA-cationic liposome complexes. Understanding the interaction with the blood components, blood cells, as well as serum proteins, is crucial for the successful development of a suitable gene delivery vector for systemic administration.
In this study, we have systematically studied a number of properties of three types of DNA-cationic liposome complexes containing Chol or DOPE as a helper lipid, or without any helper lipids: the physicochemical and structural properties, interactions with erythrocytes, a major constituent of blood cells, and in vivo transfection efficiency. Our results showed many distinct differences in the physicochemical and structural properties of DOTMA/Chol, DOTMA and DOTMA/DOPE complexes. We also demonstrated that the complexes bind to blood cells after intravenous administration and that the interaction between the complexes and erythrocytes is one of the most important factors for efficient in vivo gene transfer. DOTMA/Chol and DOTMA complexes, in which lipids had a stable and rigid lamellar structure, did not induce fusion between erythrocytes and bound stably to erythrocytes. On the other hand, lipids in DOTMA/DOPE complexes had a highly curved structure with high fluidity and induced fusion between the erythrocytes after a short period of exposure and exhibited a lower transfection efficiency.
Results
Fluorescence anisotropy of 1,6-diphenylhexatriene (DPH) in DOTMA/DOPE/Chol liposomes We used DOTMA, one of the most commonly used agents for the transfection of plasmid DNA, as a cationic lipid in vivo and in vitro. 25, 26 First of all, we examined the physicochemical and structural properties of DNAcationic liposome complexes which were considered to affect the interaction with blood components and consequent in vivo gene expression. Figure 1 shows the fluorescence anisotropy of DPH in DOTMA/DOPE/Chol liposomes as a function of the DOPE/Chol ratio. The fluorescence anisotropy was lowest in DOTMA liposomes without any helper lipids. An increase in the anisotropy of DPH was observed with the increase in Chol content, indicating that Chol reduced the mobility of the acyl chain region in the lipid bilayer of DOTMA/DOPE/Chol liposomes.
Structures of the complexes evaluated by atomic force microscopy (AFM)
The structures of the three types of DNA-cationic liposome complexes at a charge ratio of +1.12 and +2.24 were examined by AFM. At least 10 separate fields were investigated for each mixing ratio and typical images are shown in Figure 2 . Plasmid DNA complexed with DOTMA/Chol liposomes appeared shrunk and completely covered with lipids at a charge ratio of +1.12 ( Figure 2A ) and +2.24 ( Figure 2B ). At both ratios, the morphology was similar and the complexes at both ratios showed a homogeneous structure. Although the height of the complexes at +2.24 was greater than the determination limit (10 nm), the height at +2.24 was higher than that at +1.12. Plasmid DNA complexed with DOTMA liposomes at +2.24 was also completely covered with liposomes and their height was also greater than the determination limit ( Figure 2D ). The structure of DOTMA/DOPE complexes was different from that of DOTMA/Chol and DOTMA complexes. When plasmid DNA complexed with DOTMA/DOPE liposomes, the loop of DNA could be seen ( Figure 2E, F) . In contrast, the DNA complexed with DOTMA/Chol liposomes and DOTMA liposomes was completely covered with the lipid and we were unable to see the loop of DNA ( Figure  2A, B, D) . The height of the DOTMA/DOPE complexes (1.2-1.6 nm) was much smaller than that of the DOTMA/Chol and DOTMA complexes. The surface of the DOTMA/Chol and DOTMA complexes at both ratios was smooth, while that of the DOTMA/DOPE complexes was very rough. DOTMA/DOPE complexes at +1.12 were very heterogeneous and some large aggregates were observed (data not shown), however, the complexes at +2.24 had a very homogeneous structure.
Small-angle X-ray scattering (SAXS) analysis of the complexes We also investigated the structural properties of the complexes using SAXS. A very strong reflection was observed for DOTMA/Chol complexes and DOTMA/DOPE complexes at a charge ratio of +1.12. In the DOTMA/Chol complexes, second-and third-order Bragg peaks could be detected at defined positions, while only a second-order Bragg peak could be detected in the DOTMA/DOPE complexes. This indicated that the lipids in both comGene Therapy plexes had an ordered multilamellar structure (Figure 3a , b). The 2 value of the first-order Bragg peak in DOTMA/Chol complexes and DOTMA/DOPE complexes was 1.29°and 1.31°, respectively. The periodicity of the lamellar structure calculated using the Bragg equation was 6.83 and 6.73 nm for DOTMA/Chol complexes and DOTMA/DOPE complexes, respectively. DOTMA/Chol complexes at a charge ratio of +2.24 also gave the same reflection as that at +1.12 ( Figure 3c ) while DOTMA/DOPE complexes at +2.24 gave a very weak and diffuse reflection, suggesting that this complex has a disordered structure different from that of DOTMA/Chol complexes ( Figure 3d ). In the DOTMA complexes at +2.24, a first-and second-order Bragg peak could be detected at defined positions, indicating that the lipids in DOTMA complexes had a lamellar structure (data not shown).
Binding to blood cells
To examine the extent of binding of the complexes to blood cells, 32 P-labeled DNA-cationic liposome complexes were incubated with mouse whole blood and the binding to the blood cell fraction was determined. As the charge ratio between the DNA and the cationic lipid increased, the radioactivity in the blood cell fraction increased ( Figure 4 ). The amount of the DOTMA/Chol and DOTMA complexes binding to the blood cells was lower than that of DOTMA/DOPE complexes at higher charge ratios. At a ratio of +2.24, the bound fraction of DOTMA/Chol complexes, DOTMA complexes and DOTMA/DOPE complexes was 35%, 32% and 44%, respectively. In order to further investigate the amount of the complexes that binds to blood cells after intravenous injection, the complexes containing 32 P-labeled plasmid DNA were injected into mice and the radioactivity in blood and plasma was measured. Approximately half of DOTMA/Chol and DOTMA/DOPE complexes in the blood were bound to the blood cell fraction after intravenous injection although the amount of DOTMA/DOPE complexes binding to blood cells was slightly higher than that of DOTMA/Chol complexes ( Figure 5 ). 
Interaction with erythrocytes
To investigate the interaction with erythrocytes, dilute mouse erythrocyte suspension (0.1 (v/v)%) was incubated with either DOTMA/Chol complexes, DOTMA complexes or DOTMA/DOPE complexes. After a 10-min incubation with DOTMA/Chol or DOTMA complexes, no significant change was observed in the erythrocytes (Figure 6b, c) . In contrast, when the erythrocytes were incubated with DOTMA/DOPE complexes, fusion and aggregation between the erythrocytes occurred ( Figure  6d ). When DOTMA/DOPE complexes were incubated with a greater amount of erythrocytes (1 (v/v)%), fusion and aggregation were more rapid (data not shown). No aggregation or fusion was observed in the control ( Figure  6a ). Similar results were observed when the complexes were incubated with diluted mouse whole blood although the fusion was slightly delayed (data not shown).
In vivo transfection with complexes preincubated with mouse serum or erythrocytes To examine the effect of interaction with serum proteins on the in vivo transfection efficiency, the three types of complexes at a charge ratio of +2.24 were preincubated with mouse serum for different periods of time and their transfection efficiency was evaluated based on the level of gene expression in the lung after intravenous injection. Pre-incubation of all the complexes with mouse serum did not reduce the in vivo transfection efficiency when the complexes were incubated with serum for up to 30 min ( Figure 7 ). In the case of DOTMA/DOPE complexes, the transfection efficiency slightly increased on increasing the incubation time.
DNA-cationic liposome complexes interact with blood cells as well as serum proteins. To assess the effect of erythrocytes, the complexes were preincubated with mouse erythrocyte suspensions at different concentrations for 5 min and then administered intravenously to mice. Luciferase expression in the lung produced by all complexes fell significantly after pre-incubation with erythrocytes at concentrations greater than 20 (v/v)% (Figure 8) . A more dramatic reduction in gene expression was observed for DOTMA/DOPE complexes compared with DOTMA/Chol and DOTMA complexes. Gene expression in other organs produced by DOTMA/DOPE complexes was also abolished under these conditions (data not shown).
Identification of transfected cell types in lung
In order to investigate which cell types in the lung were transfected by intravenous injection of DOTMA/Chol complexes, mice received intravenous injections of the complexes containing LacZ DNA. Six hours after injection, the lungs were removed and frozen sections were prepared. There was localized gene expression throughout the distal lung (Figure 9a) . No expression was observed in the lung of mice treated with 5% dextrose solution (data not shown). At higher magnification, the primary location of LacZ expression appeared to be capillary endothelial cells located within the alveolar septum (Figure 9b ).
Discussion
The present study has demonstrated that rapid interaction with erythrocytes in the blood can occur and this is an important determinant of the in vivo gene transfer The charge ratio, the ratio of the negative charge on the phosphate group of the DNA to the positive charge on the cationic lipid, is one of the most important factors involved in in vivo systemic gene delivery. In this study, we selected a charge ratio of +2.24 for the in vivo experiments, although higher gene expression would be expected with complexes prepared at higher charge ratios. It has been reported that DNA-DOTMA/Chol liposome complexes at 48:1 (cationic lipid:DNA, nmol:g), which corresponds to a charge ratio of approximately +14.4, showed higher transfection efficiency than that at a lower ratio. 26 However, when cationic liposomes are present in great excess compared with DNA, eg a charge ratio greater than +2.53, the complex formulation contains free liposomes which may affect the transfection potency of the complexes. 27 In fact, Song and Liu 28 showed that free cationic liposomes enhanced the transfection activity of DNA-cationic lipid complexes in vivo. Therefore, we decided to use a charge ratio of +2.24 in order to investigate the physicochemical and biological properties of the complexes themselves without any effect from free liposomes. Before the in vivo experiments, we evaluated a number of the physicochemical properties of the complexes including their particle size and zeta potential. No great differences were observed in these macroscopic parameters (approximately 120 nm and +40 mV). Based on these findings, we carried out AFM and SAXS studies in order to characterize the complexes in more detail. Analysis by AFM and SAXS showed that the structural and physicochemical properties of DNA-cationic liposome complexes are significantly affected by the neutral helper lipid component. Judging from the results of the AFM and SAXS analysis, lipids in DOTMA/Chol and DOTMA complexes had a stable lamellar structure. Plasmid DNA appeared to be localized to the interior of the liposomes and be sandwiched between lipid bilayers in these complexes. The AFM images showed that plasmid DNA was completely covered with lipid membrane in DOTMA/Chol and DOTMA complexes. In addition, these complexes were bulky with a smooth surface. This was probably due to the fact that the DNA would be sandwiched between lipid bilayers. Templeton et al 19 reported that the DNA was localized between lipid bilayers of DOTAP/Chol liposomes. DOTMA/Chol and DOTMA complexes in our analysis are considered to have a similar structure to DOTAP/Chol complexes. These authors also reported that the predicted thickness of the lipid bilayer plus the DNA chain was 6.5 nm, which corresponded well to our SAXS data (6.83 nm). In our AFM images (Figure 2) , the DOTMA/Chol com-plexes were not completely round, unlike the cationic lipid-protamine-DNA complexes. 22 It was probably due to the fact that AFM could not clearly visualize soft materials like lipids. DOTMA/Chol and DOTMA complexes, in which lipids had a stable lamellar structure, did not induce fusion between erythrocytes ( Figure 6 ). A lamellar structure is very important for the stability of the complexes in the presence of biological components. Boukhnikachvili et al 29 reported that the transfection efficiency in the presence of serum was maintained when DOGS-DNA complexes had a lamellar structure. Moreover, Koltover et al 15 demonstrated that DNA-cationic liposome complexes with a lamellar structure stably bound to anionic liposomes used as a model of a biomembrane and did not fuse. DOTMA/Chol and DOTMA complexes in which lipids had a stable lamellar structure exhibited a similar interaction with erythrocytes ( Figure 6 ). In contrast, lipids in DOTMA/DOPE complexes at +2.24 had an unstable, highly curved structure with high fluidity. SAXS analysis showed no clear reflection indicating a lamellar structure (Figure 3d ). The AFM images showed that the loop of plasmid DNA was connected to the liposomes in DOTMA/DOPE complexes ( Figure 2 ). DOTMA/DOPE complexes appeared to have a similar structure to the 'spaghetti-meatball structure' reported by Sternberg et al. 30 The loop of plasmid DNA was similar to these tubular spaghetti-like structures. It appeared that a single lipid bilayer tubule surrounded the DNA chain. DOPE can adopt such a highly curved structure due to its unique structure. The flattened structure of DOTMA/DOPE complexes might be due to their tubular structure. High membrane curvature is one of the important factors for fusion 31 and spaghetti-like structures, in which lipids had an extremely high curvature, would play an important role in the fusion between erythrocytes. The SAXS analysis showed a very diffuse and weak reflection for DOTMA/DOPE complexes at a charge ratio of +2.24, which was very different from that of DOTMA/Chol complexes ( Figure 3) . A higher fluctuation of the bilayer tubules in DOTMA/DOPE complexes, due to the higher fluidity of the acyl chain in DOTMA/DOPE complexes than that in DOTMA/Chol complexes, and an electrostatic repulsion between cationic lipids may be the reason why a very diffuse and weak reflection was observed in our experimental system. The fluidity of the acyl region of lipids is also another important factor for fusion. Unsaturation of the acyl chain, which has a high fluidity, appears to be crucial for fusion. 31 Fluorescence anisotropy also indicated that inclusion of DOPE increased the fluidity (Figure 1) , which explains partly the high yield of fusion between erythrocytes. DOPE itself also plays an important role in fusion between membranes due to its unique structure. DOPE has a high propensity to form a hexagonal phase. Hexagonal formation is significantly related to inverted micelle intermediate formation, which is one of the processes involved in membrane fusion. 32 After incubation with whole blood, the three types of complexes showed a similar apparent binding ratio to the blood cell fraction (Figure 4) , implying that all the complexes bind to plasma proteins and blood cells via electrostatic forces to a similar extent. The slightly greater fraction of DOTMA/DOPE complexes bound to blood cells might be related to the fusion with erythrocytes. We also showed that a similar rapid interaction of the DNAGene Therapy cationic liposome complexes with these blood components takes place after intravenous injection into mice ( Figure 5 ). We found that approximately half the DOTMA/DOPE and DOTMA/Chol complexes in the blood were bound to the blood cell fraction 1 min after intravenous administration. The DOTMA/DOPE complexes also induced fusion between the erythrocytes in diluted whole blood (data not shown), indicating that fusion can occur in the presence of serum proteins. These results suggest that the interaction with erythrocytes, as shown in Figure 6 , would occur in the veins after intravenous injection.
Pre-incubation of DOTMA/DOPE complexes with erythrocyte suspension reduced their in vivo transfection efficiency dramatically while, in contrast, gene expression by DOTMA and DOTMA/Chol complexes was fairly resistant to such pre-incubation (Figure 8 ). These data suggest that DOTMA/Chol and DOTMA complexes stably bind to erythrocytes without much loss of transfection activity, whereas the binding and subsequent fusion with erythrocytes significantly reduces the transfection activity of DOTMA/DOPE complexes. Although the DOTMA/Chol and DOTMA complexes can bind to blood cells, a fraction of the erythrocyte-binding complexes may still be active as far as transfection is concerned because the complexes do not induce fusion between erythrocytes. During passage through the lung capillaries, some of the complexes may dissociate from the erythrocytes without any loss of lipid components and change in their structure. Then, the complexes may be transferred to the lung endothelial cells and internalized by endocytosis. McLean et al 24 reported that DNA-DOTIM/Chol complexes were internalized by endocytosis. Erythrocytes dissociated from the complexes would pass through the lung. The diameter of erythrocytes (7 m) is greater than that of the capillaries (5 m), which would make it easy for the complexes to be transferred to the endothelial cells. On the other hand, DOTMA/DOPE complexes induce fusion between erythrocytes. When DOTMA/DOPE complexes caused fusion and aggregation between the erythrocytes, their lipid components were considered to be absorbed into fusing erythrocyte membrane. In addition, DOTMA/DOPE complexes fused with erythrocytes were unable to bind to the endothelial cells. We confirmed that DOTMA/DOPE complexes accumulated in the lung immediately after injection, however, they were removed from the lung rapidly (data not shown). These observations also account for the decrease in their transfection activity. We speculate that the DOTMA/DOPE complexes fuse with and/or between erythrocytes and embolize the lung capillaries due to their large size. Consequently, they are no longer available for efficient internalization by the endothelial cells. The complexes which were embolized with erythrocytes would be washed away in the bloodstream. Very recent observations in our rat lung perfusion experiments support this. 33 The erythrocytes incubated with DOTMA/Chol complexes before perfusion did not accumulate in the lung although there was a high degree of accumulation of DOTMA/Chol complexes. In contrast, a major fraction of the erythrocytes incubated with DOTMA/DOPE complexes accumulated in the lung with DOTMA/DOPE complexes. Therefore, DOTMA/Chol complexes are mainly taken up by endothelial cells in the lung 24 and gene expression has been seen in endothelial cells ( Figure 9 ). 34 DOTMA/Chol and DOTMA complexes did not induce fusion between erythrocytes, however, the transfection efficiency with DOTMA complexes in the lung was lower than that with DOTMA/Chol complexes. Although lipids in DOTMA complexes exhibited a lamellar structure, DOTMA liposomes showed the highest fluidities among the three types of the cationic liposomes (Figure 1 ). This may be due to electrostatic repulsion between DOTMA molecules. We consider that DOTMA complexes have an intermediate stability to erythrocytes that is somewhere between that of DOTMA/Chol and DOTMA/DOPE complexes. The lower degree of fusion activity of DOTMA complexes in Figure 6 may be due to the low erythrocyte concentration. It is reasonable that an intermediate degree of fusion would occur after intravenous injection of DOTMA complexes. Li et al 22 reported that cationic lipid-protamine-DNA complexes (LPD) without helper lipid showed an intermediate residence time in the lung between Chol-containing LPD and DOPE-containing LPD. This may be due to intermediate fusion activity of DOTMA complexes.
Interaction with serum proteins is also one of the major barriers which systemic gene delivery has to overcome. Li et al 21, 22 reported that LPD were enriched in a protein with a molecular weight corresponding to serum albumin and that further interaction of lipid vectors with serum proteins led to their disintegration, DNA release and degradation. In particular, DOPE-containing formulations disintegrated more rapidly when incubated with serum than Chol-containing formulations. A greater amount of serum proteins was bound to DOPE-containing formulations. 21 These results could explain why cationic lipid complexes exhibit dramatic differences in their in vivo transfection efficiency. However, in our experiment, a short (5-30 min) incubation of both complexes with serum did not significantly affect the in vivo transfection activity of any of the complexes (Figure 7 ). The gene expression by DOTMA/DOPE complexes increased gradually as the incubation time increased. This may be due to the fact that adsorption of serum proteins led to a reduction in the zeta potential and a consequent reduction in the interaction with erythrocytes. These results do not contradict a previous report that pre-incubation of lipid vectors with serum for a longer period gradually inactivated their in vivo transfection efficiency. 22 A difference in incubation time could explain the difference in the gene expression in our experiments.
In summary, we have shown in this study that the interaction with erythrocytes is one of the most important factors governing in vivo intravenous gene transfer. DNA-cationic liposome complexes bind to blood cells after intravenous administration. However, DOTMA/Chol and DOTMA complexes, which are very efficient vectors for intravenous delivery, bind to erythrocytes without fusion due to the stable lamellar structure of the lipids. DOTMA/DOPE complexes, which have a low in vivo transfection efficiency, induced fusion between the erythrocytes due to the highly curved structure of the lipids with high fluidity. The present findings suggest that we must consider the interaction between cationic lipid vectors and erythrocytes, as well as serum proteins when cationic lipid vectors are used for systemic gene therapy.
Materials and methods
Chemicals DOTMA (N-[1-(2,3-dioleyloxy) propyl]-N,N,N-trimethylammonium) was purchased from Tokyo Kasei (Tokyo, Japan) and DOPE (dioleoylphosphatidylethanolamine) was purchased from Sigma (St Louis, MO, USA). Cholesterol and Clear-sol I were obtained from Nacalai Tesque Inc (Kyoto, Japan) and [ 32 P]-dCTP was purchased from Amersham (Tokyo, Japan). All other chemicals were obtained commercially as reagent-grade products.
Plasmid DNA A plasmid DNA pCMV-Luc and pCMV-LacZ were constructed by subcloning the HindIII/XbaI firefly luciferase and ␤-galactosidase (␤-gal) cDNA fragments from pGL3-control vector (Promega, Madison, WI, USA) into the polylinker of pcDNA3 vector (Invitrogen, Carlsbad, CA, USA), respectively. Plasmid DNA was amplified in the DH5 strain of Escherichia coli, and purified using a Qiagen Plasmid Giga Kit (Qiagen GmbH, Hilden, Germany). The concentration of plasmid DNA was measured by UV absorption at 260 nm. Plasmid DNA purity was assessed using agarose gel electrophoresis and A260/A280 ratios. For in vivo distribution of plasmid DNA-cationic liposome complexes and binding assay to blood cells, plasmid DNA was radiolabeled with 32 P using a nick translation kit (Takara, Japan) and [
P]-dCTP.
Preparation and characterization of cationic liposomes Liposomes (DOTMA alone, DOTMA/Chol, DOTMA/ DOPE, 1/1 molar ratio) were prepared by allowing the lipids to dry as a thin film in a round-bottomed flask using a rotary evaporator, and then resuspending the dried film in 5% w/v glucose by vortexing. After hydration, the dispersions were sonicated for 15 min in a bath sonicator. They were then passed 10 times through an extruder fitted with a 0.1 m pore membrane and finally through a 0.45 m filter. The lipid concentrations of DOTMA/DOPE and DOTMA/Chol liposomes were determined by phosphorus analysis, or using an enzyme assay kit, Free cholesterol E-test Wako, obtained from Wako Pure Chemicals (Osaka, Japan). In the case of DOTMA liposomes, the liposome suspension was used without extrusion.
Fluorescence anisotropy of 1,6-diphenylhexatriene (DPH) in DOTMA/DOPE/Chol liposomes Liposomes containing DOTMA in the indicated molar ratios with DOPE and Chol were prepared as described above. The liposomes were labeled with 0.5% 1,6-diphenylhexatriene (DPH). Liposome suspensions (20 m total lipids) were stirred with a magnetic stirrer. The fluorescence anisotropy, r, was measured using a spectrofluorometer at 37°C; the excitation wavelength was 360 nm and the emission wavelength was 434 nm. The fluorescence anisotropy was then calculated as described in a previous report. 35 Atomic force microscopy (AFM) One mg DOTMA/ml cationic liposomes was diluted to 0.05 mg DOTMA/ml and an aliquot was mixed with 1 g plasmid DNA in a similar volume of distilled water. The solutions were incubated for 30 min at room temperature and then diluted. Twenty l was deposited on to freshly cleaved mica, and allowed to remain in place for 90 s and then the unadsorbed material was washed off with four drops distilled water. The mica surface was then dried with a stream of nitrogen. The AFM images were observed in the tapping mode in air on a Nanoscope AFM system (Digital Instruments, Santa Barbara, CA, USA). The imaging was carried out with 125 m silicon single crystal cantilevers (NCH-10T). The scan rate was between 1 and 3 Hz for a 512 × 512 pixel image. Images were flattened before analysis.
Small-angle X-ray scattering (SAXS) Plasmid DNA-cationic liposome complexes were prepared by mixing plasmid DNA solution (2 mg/ml) and cationic liposome suspensions (20 mg DOTMA/ml) at charge ratios of +1.12 and +2.24. The complexes were then transferred to a quartz glass capillary (Glas, Berlin, Germany; 1.5 mm outer diameter, 1/100 mm wall thickness). Small-angle X-ray scattering experiments were performed with Ni-filtered CuK␣ radiation (wavelength: = 0.15418 nm) produced by a Rigaku RU-200 X-ray generator (40 kV, 100 mA) with a double pinhole collimator (0.3 mm × 0.3 mm). The diffraction pattern was recorded on an imaging plate (Fuji, Kanagawa, Japan; Photofilms, HR-IIIN) using a flat camera with a camera length of approximately 300 mm. The recorded images were read on a Rigaku imaging plate reader, and the digitized data were analyzed on a Rigaku RINT 2000 system. The exposure time was 105 min and the temperature was 23°C. The periodicity of the lamellar structure (d) was calculated from the peak position of the diffracted X-rays using the Bragg equation; 2dsin = , where is the wavelength of the X-ray and 2 is the scattering angle.
Mouse serum and erythrocyte suspension Mouse serum was prepared by the method of Takino et al. 36 Briefly, mouse serum was isolated from fresh whole blood obtained from ICR mice. Blood was collected from the vena cava under anesthesia without heparin treatment and allowed to stand for 3 h at 37°C and then overnight at 4°C. Serum was collected after centrifugation. An erythrocyte suspension was prepared as described in a previous report. 37 Blood was collected in a heparinized syringe from ICR mice and washed three times with 150 mm NaCl, 10 mm Hepes buffer, after which the packed erythrocytes were dispersed in 150 mm NaCl, 10 mm Hepes buffer.
Binding to blood cells Fresh blood from ICR mice was collected with a heparinized syringe. The complexes were prepared as follows. Diluted 32 P-labeled plasmid DNA solution was added to cationic liposomes (1 mg DOTMA/ml) at various charges. Twenty l of complex solutions and 100 l whole blood were mixed to give a final concentration of 0.021 mg DNA/ml. After a 3-min incubation, the mixtures were centrifuged at 5000 r.p.m. for 5 min at 4°C and 50 l of the supernatants was used to measure the radioactivity. The hematocrit of mouse blood was assumed to be 47%. 38 The fractions of the complexes binding to blood cells were estimated by subtracting the radioactivity of the plasma fraction from the total radioactivity. This concentration corresponds roughly to that obtained immediGene Therapy ately after intravenous injection, assuming that the blood volume of a 20 g mouse is 2 ml. For measurement of binding to blood cells in vivo, the complexes containing 32 P-labeled plasmid DNA were injected into mice at a dose of 25 g plasmid DNA. Blood was collected from the vena cava under anesthesia at the indicated times. An aliquot of the blood was subjected to centrifugation to obtain plasma. Both blood and plasma samples were digested with Soluene-350 following incubation overnight at 45°C. Following digestion, 2-propanol, H 2 O 2 , HCl, and Clear-sol I were added to each sample. The samples were then stored overnight and the radioactivity was measured using a scintillation counter (LSA-500, Beckman, Tokyo, Japan). The fractions of the complexes binding to blood cells were estimated as described above.
Interaction with erythrocytes
Fresh blood from ICR mice was collected with a heparinized syringe. Erythrocytes were washed three times on ice in order to remove serum proteins and resuspended in 150 mm NaCl, 10 mm Hepes buffer. Six hundred microliters of 0.1% erythrocyte suspension (erythrocyte volume/erythrocyte suspension volume %) was mixed with 50 l of the complexes at a charge ratio of +2.24, and incubated for 10 min at 37°C.
In vivo transfection experiments
For the in vivo transfection experiments, diluted plasmid DNA (0.33 mg/ml) was added to cationic liposomes (1 mg DOTMA/ml) at a charge ratio of +2.24. The mixtures were incubated at room temperature for 30 min before use. Female ICR mice, 5 weeks of age, were used. Mice in groups of three were each injected intravenously with a dose of 25 g plasmid DNA complexed with either DOTMA/Chol, DOTMA, or DOTMA/DOPE liposomes. Twenty-four hours after i.v. injection, the mice were bled from the inferior vena cava under anesthesia and then killed. Tissues (lung, heart, liver, spleen, kidney) were collected and washed twice with cold saline. The tissues were homogenized with lysis buffer (0.05% Triton X-100, 2 mm EDTA, 0.1 m Tris, pH 7.8) using a homogenizer. After three cycles of freezing and thawing, the homogenates were centrifuged at 14 000 r.p.m. for 15 min at 4°C and 20 l of the supernatant was used to measure the luciferase activity. The luciferase activity in the tissues was normalized with respect to the protein content of the tissues. To evaluate the effect of pre-incubation with mouse serum on in vivo gene expression, 200 l of the complexes was mixed with 100 l mouse serum (100%) and the mixtures were incubated at 37°C for different periods before injection. In the case of controls, the complexes were mixed with 150 mm NaCl, 10 mm Hepes buffer. To investigate the effect of pre-incubation with mouse erythrocytes, 200 l of the complexes was mixed with 100 l erythrocyte suspensions at different concentrations (erythrocyte volume/ erythrocyte suspension volume %) and the mixtures were incubated at 37°C for 5 min before injection.
X-gal staining
Plasmid DNA-DOTMA/Chol complexes were injected into the tail vein of mice at a dose of 50 g DNA per mouse. Six hours after intravenous injection, the lung was intratracheally and intravascularly infused with OCT/PBS (2:1, v/v) and then the lung was removed,
